Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antibody-drug conjugates or ADCs are a class of biological drugs designed as targeted therapies for cancer treatment. Unlike chemotherapy, ADC is designed to target and kill tumor cells while preserving healthy cells.
By 2030, its compound annual growth rate (CAGR) will grow by more than 20% due to its growing popularity and therapeutic potential. ADC has six commercially available drugs, which are currently considered to be effective targeted anti-cancer therapies with potential for the treatment of many other diseases. The analysis said that the success of such products can be attributed to their ability to effectively identify and eliminate disease-related cells/pathogens, while the risk of side effects related to treatment is greatly reduced.
Antibody drug conjugates are currently considered to be effective targeted anti-cancer therapies, which will lead to market growth. The increase in the number of cancers has promoted the development of the market. The government and medical institutions have increased investment in research and development of antibody-drug conjugates, which has promoted the further expansion of the market.
This report elaborates on the current development of the Antibody-drug Conjugates industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
ImmunoGen
Takeda
Roche
By Type:
Kadcyla
Adcetris
By Application:
Lymphoma
Breast Cancer
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Antibody-drug Conjugates Market Overview 2018-2029
-
1.1 China Antibody-drug Conjugates Industry Development Overview
-
1.2 China Antibody-drug Conjugates Industry Development History
-
1.3 China Antibody-drug Conjugates Industry Market Size (2018-2029)
-
1.4 China Antibody-drug Conjugates Market Analysis by Type from Production Side
-
1.4.1 China Antibody-drug Conjugates Production Volume, Production Value and Growth Rate of Kadcyla (2018-2029)
-
1.4.2 China Antibody-drug Conjugates Production Volume, Production Value and Growth Rate of Adcetris (2018-2029)
-
1.5 China Antibody-drug Conjugates Market Analysis by Application from Consumption End
-
1.5.1 China Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate of Lymphoma (2018-2029)
-
1.5.2 China Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)
-
1.6 China Antibody-drug Conjugates Market Analysis by Region
-
1.6.1 North China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
Chapter 2 China Antibody-drug Conjugates Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Antibody-drug Conjugates Market Status and Competition at home and abroad in 2023
-
2.2.2 China Antibody-drug Conjugates Market Status and Competition Analysis in 2023
-
2.2.3 China Antibody-drug Conjugates Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Antibody-drug Conjugates Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Antibody-drug Conjugates Industry Development
Chapter 3 Antibody-drug ConjugatesIndustry Chain Analysis
-
3.1 Antibody-drug Conjugates Industry Chain
-
3.2 Antibody-drug Conjugates Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Antibody-drug Conjugates Market
-
3.3 Antibody-drug Conjugates Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Antibody-drug Conjugates Market
Chapter 4 China Antibody-drug Conjugates Market, by Type
-
4.1 China Antibody-drug Conjugates Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Antibody-drug Conjugates Total Production Volume and Growth Rate from Production Side
-
4.5 China Antibody-drug Conjugates Production Volume and Growth Rate, by Type
-
4.5.1 China Antibody-drug Conjugates Production Volume and Growth Rate of Kadcyla
-
4.5.2 China Antibody-drug Conjugates Production Volume and Growth Rate of Adcetris
Chapter 5 China Antibody-drug Conjugates Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Antibody-drug Conjugates Total Market Size and Growth Rate from Consumption End
-
5.5 China Antibody-drug Conjugates Market Size and Growth Rate, by Application
-
5.5.1 China Antibody-drug Conjugates Market Size and Growth Rate of Lymphoma
-
5.5.2 China Antibody-drug Conjugates Market Size and Growth Rate of Breast Cancer
Chapter 6 China Antibody-drug Conjugates Market, by Region
-
6.1 China Antibody-drug Conjugates Production Volume and Production Value, by Region
-
6.2 China Antibody-drug Conjugates Sales Volume and Sales Value, by Region
Chapter 7 North China Antibody-drug Conjugates Market Analysis
-
7.1 North China Antibody-drug Conjugates Market, by Type
-
7.2 North China Antibody-drug Conjugates Market, by Application
Chapter 8 Central China Antibody-drug Conjugates Market Analysis
-
8.1 Central China Antibody-drug Conjugates Market, by Type
-
8.2 Central China Antibody-drug Conjugates Market, by Application
Chapter 9 South China Antibody-drug Conjugates Market Analysis
-
9.1 South China Antibody-drug Conjugates Market, by Type
-
9.2 South China Antibody-drug Conjugates Market, by Application
Chapter 10 East China Antibody-drug Conjugates Market Analysis
-
10.1 East China Antibody-drug Conjugates Market, by Type
-
10.2 East China Antibody-drug Conjugates Market, by Application
Chapter 11 Northeast China Antibody-drug Conjugates Market Analysis
-
11.1 Northeast China Antibody-drug Conjugates Market, by Type
-
11.2 Northeast China Antibody-drug Conjugates Market, by Application
Chapter 12 Southwest China Antibody-drug Conjugates Market Analysis
-
12.1 Southwest China Antibody-drug Conjugates Market, by Type
-
12.2 Southwest China Antibody-drug Conjugates Market, by Application
Chapter 13 Northwest China Antibody-drug Conjugates Market Analysis
-
13.1 Northwest China Antibody-drug Conjugates Market, by Type
-
13.2 Northwest China Antibody-drug Conjugates Market, by Application
Chapter 14 Company Profiles
-
14.1 ImmunoGen
-
14.1.1 ImmunoGen Company Profile
-
14.1.2 ImmunoGen Antibody-drug Conjugates Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Takeda
-
14.2.1 Takeda Company Profile
-
14.2.2 Takeda Antibody-drug Conjugates Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Roche
-
14.3.1 Roche Company Profile
-
14.3.2 Roche Antibody-drug Conjugates Market Performance
-
14.3.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Antibody-drug Conjugates Industry Research Conclusions
-
15.2 Antibody-drug Conjugates Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Antibody-drug Conjugates Industry Market Size (2018-2029)
-
Figure China Antibody-drug Conjugates Production Volume, Production Value and Growth Rate of Kadcyla (2018-2029)
-
Figure China Antibody-drug Conjugates Production Volume, Production Value and Growth Rate of Adcetris (2018-2029)
-
Figure China Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate of Lymphoma (2018-2029)
-
Figure China Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)
-
Figure North China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
Figure Central China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
Figure South China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
Figure East China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Antibody-drug Conjugates Market Size and Growth Rate from 2018-2029
-
Figure Antibody-drug Conjugates Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Antibody-drug Conjugates Market Share by Type in 2018
-
Figure China Antibody-drug Conjugates Market Share by Type in 2023
-
Figure China Antibody-drug Conjugates Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Antibody-drug Conjugates Production Volume and Growth Rate of Kadcyla (2018-2023)
-
Figure China Antibody-drug Conjugates Production Volume and Growth Rate of Adcetris (2018-2023)
-
Figure China Antibody-drug Conjugates Market Share by Application in 2018
-
Figure China Antibody-drug Conjugates Market Share by Application in 2023
-
Figure China Antibody-drug Conjugates Total Market Size and Growth Rate from Consumption End
-
Figure China Antibody-drug Conjugates Market Size and Growth Rate of Lymphoma (2018-2023)
-
Figure China Antibody-drug Conjugates Market Size and Growth Rate of Breast Cancer (2018-2023)
-
Table China Antibody-drug Conjugates Production Volume by Region (2018-2023)
-
Table China Antibody-drug Conjugates Production Volume Share by Region (2018-2023)
-
Figure China Antibody-drug Conjugates Production Volume Share by Region (2018-2023)
-
Table China Antibody-drug Conjugates Production Value by Region (2018-2023)
-
Table China Antibody-drug Conjugates Production Value Share by Region (2018-2023)
-
Figure China Antibody-drug Conjugates Production Value Share by Region (2018-2023)
-
Table China Antibody-drug Conjugates Sales Volume by Region (2018-2023)
-
Table China Antibody-drug Conjugates Sales Volume Share by Region (2018-2023)
-
Figure China Antibody-drug Conjugates Sales Volume Share by Region (2018-2023)
-
Table China Antibody-drug Conjugates Sales Value by Region (2018-2023)
-
Table China Antibody-drug Conjugates Sales Value Share by Region (2018-2023)
-
Figure China Antibody-drug Conjugates Sales Value Share by Region (2018-2023)
-
Table North China Antibody-drug Conjugates Production Volume by Type (2018-2023)
-
Table North China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Figure North China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Table North China Antibody-drug Conjugates Sales Volume by Application (2018-2023)
-
Table North China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Figure North China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Table Central China Antibody-drug Conjugates Production Volume by Type (2018-2023)
-
Table Central China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Figure Central China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Table Central China Antibody-drug Conjugates Sales Volume by Application (2018-2023)
-
Table Central China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Figure Central China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Table South China Antibody-drug Conjugates Production Volume by Type (2018-2023)
-
Table South China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Figure South China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Table South China Antibody-drug Conjugates Sales Volume by Application (2018-2023)
-
Table South China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Figure South China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Table East China Antibody-drug Conjugates Production Volume by Type (2018-2023)
-
Table East China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Figure East China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Table East China Antibody-drug Conjugates Sales Volume by Application (2018-2023)
-
Table East China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Figure East China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Table Northeast China Antibody-drug Conjugates Production Volume by Type (2018-2023)
-
Table Northeast China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Figure Northeast China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Table Northeast China Antibody-drug Conjugates Sales Volume by Application (2018-2023)
-
Table Northeast China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Table Southwest China Antibody-drug Conjugates Production Volume by Type (2018-2023)
-
Table Southwest China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Figure Southwest China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Table Southwest China Antibody-drug Conjugates Sales Volume by Application (2018-2023)
-
Table Southwest China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Table Northwest China Antibody-drug Conjugates Production Volume by Type (2018-2023)
-
Table Northwest China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Figure Northwest China Antibody-drug Conjugates Production Volume Share by Type (2018-2023)
-
Table Northwest China Antibody-drug Conjugates Sales Volume by Application (2018-2023)
-
Table Northwest China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Antibody-drug Conjugates Sales Volume Share by Application (2018-2023)
-
Table ImmunoGen Company Profile
-
Table ImmunoGen Antibody-drug Conjugates Revenue, Price and Gross (2018-2023)
-
Table Takeda Company Profile
-
Table Takeda Antibody-drug Conjugates Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Antibody-drug Conjugates Revenue, Price and Gross (2018-2023)
-
